CD19/CD22-targeted Chimeric Antigen Receptor Engineered T Cell (CART) in B-Cell Acute Lymphoblastic Leukemia.

Name: CD19/CD22-targeted Chimeric Antigen Receptor Engineered T Cell (CART) in B-Cell Acute Lymphoblastic Leukemia.
Published: 2017
License: Public Domain

Shanghai Unicar-Therapy Bio-medicine Technology Co.,Ltd · 2017

ClinicalTrials.gov · Datasets · License: Public Domain · 2017

Open Source ↗

leukemia

leukemia, b-cell, cd19, cd22, interventional, phase1, phase2

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

CD19/CD22-targeted Chimeric Antigen Receptor Engineered T Cell (CART) in B-Cell Acute Lymphoblastic Leukemia.

Related documents